{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:27:31Z","timestamp":1789198051117,"version":"build-2803163510"},"reference-count":289,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cca.2026.121122","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T15:21:25Z","timestamp":1780154485000},"page":"121122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["CircRNAs as central regulators of Immunometabolic crosstalk in hepatocellular carcinoma"],"prefix":"10.1016","volume":"591","author":[{"given":"Seerwan Hamadameen","family":"Sulaiman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebaz Anwar","family":"Omer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemn A.H.","family":"Barzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunar Yasin","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avan Bazid","family":"Qader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan Hashm","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darya Kaife","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Wezhawan","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoshyar Saadi","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2026.121122_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cca.2026.121122_bb0010","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature11928","article-title":"Circular RNAs are a large class of animal RNAs with regulatory potency","volume":"495","author":"Memczak","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cca.2026.121122_bb0015","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature11993","article-title":"Natural RNA circles function as efficient microRNA sponges","volume":"495","author":"Hansen","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cca.2026.121122_bb0020","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13045-021-01145-8","article-title":"Circular RNAs: characteristics, biogenesis, mechanisms and functions in liver cancer","volume":"14","author":"Shen","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cca.2026.121122_bb0025","article-title":"Emerging roles of circular RNAs in liver cancer","volume":"4","author":"Louis","year":"2022","journal-title":"JHEP Rep."},{"key":"10.1016\/j.cca.2026.121122_bb0030","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.3389\/fonc.2019.01404","article-title":"MicroRNAs in tumor cell metabolism: roles and therapeutic opportunities","volume":"9","author":"Pedroza-Torres","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cca.2026.121122_bb0035","article-title":"Circular RNAs in hepatocellular carcinoma: emerging functions to clinical significances","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cca.2026.121122_bb0040","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O'Neill","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cca.2026.121122_bb0045","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jhep.2014.10.029","article-title":"Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma","volume":"62","author":"Yeung","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cca.2026.121122_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00595-011-0058-8","article-title":"Role of tumor-associated macrophages in the progression of hepatocellular carcinoma","volume":"42","author":"Shirabe","year":"2012","journal-title":"Surg. Today"},{"key":"10.1016\/j.cca.2026.121122_bb0055","article-title":"Therapeutically targeting essential metabolites to improve immunometabolism manipulation after liver transplantation for hepatocellular carcinoma","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2026.121122_bb0060","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1073\/pnas.1001006107","article-title":"Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function","volume":"107","author":"Hu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cca.2026.121122_bb0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejphar.2018.07.007","article-title":"The role of ASCT2 in cancer: a review","volume":"837","author":"Liu","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cca.2026.121122_bb0070","doi-asserted-by":"crossref","DOI":"10.4161\/21624011.2014.954829","article-title":"Myeloid derived suppressor cells\u2014an overview of combat strategies to increase immunotherapy efficacy","volume":"4","author":"Draghiciu","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.cca.2026.121122_bb0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/bs.acr.2020.10.004","article-title":"Atypical immunometabolism and metabolic reprogramming in liver cancer: deciphering the role of gut microbiome","volume":"149","author":"Golonka","year":"2021","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.cca.2026.121122_bb0080","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.cell.2022.04.021","article-title":"Circular RNAs: characterization, cellular roles, and applications","volume":"185","author":"Liu","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.cca.2026.121122_bb0085","doi-asserted-by":"crossref","first-page":"9331","DOI":"10.3390\/ijms15069331","article-title":"A view of pre-mRNA splicing from RNase R resistant RNAs","volume":"15","author":"Suzuki","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2026.121122_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1106665","article-title":"Circular RNAs in hepatocellular carcinoma: biogenesis, function, and pathology","volume":"14","author":"Rao","year":"2023","journal-title":"Front. Genet."},{"key":"10.1016\/j.cca.2026.121122_bb0095","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.cell.2018.12.021","article-title":"The landscape of circular RNA in cancer","volume":"176","author":"Vo","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.cca.2026.121122_bb0100","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.celrep.2014.12.002","article-title":"Exon circularization requires canonical splice signals","volume":"10","author":"Starke","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.cca.2026.121122_bb0105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fonc.2018.00179","article-title":"Circular RNAs in cancer\u2013lessons learned from microRNAs","volume":"8","author":"Dragomir","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cca.2026.121122_bb0110","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41580-020-0243-y","article-title":"The expanding regulatory mechanisms and cellular functions of circular RNAs","volume":"21","author":"Chen","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cca.2026.121122_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2024.101986","article-title":"Role of microRNAs in neutrophil extracellular trap formation and prevention: systematic narrative review","volume":"78","author":"Hussen","year":"2024","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.cca.2026.121122_bb0120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.molcel.2014.08.019","article-title":"circRNA biogenesis competes with pre-mRNA splicing","volume":"56","author":"Ashwal-Fluss","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cca.2026.121122_bb0125","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12060","article-title":"Comprehensive identification of internal structure and alternative splicing events in circular RNAs","volume":"7","author":"Gao","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cca.2026.121122_bb0130","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41581-021-00465-9","article-title":"Circular RNAs in kidney disease and cancer","volume":"17","author":"van Zonneveld","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.cca.2026.121122_bb0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.gde.2017.11.007","article-title":"circRNAs in cancer","volume":"48","author":"Patop","year":"2018","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.cca.2026.121122_bb0140","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nsmb.2959","article-title":"Exon-intron circular RNAs regulate transcription in the nucleus","volume":"22","author":"Li","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.cca.2026.121122_bb0145","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.molcel.2013.08.017","article-title":"Circular intronic long noncoding RNAs","volume":"51","author":"Zhang","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cca.2026.121122_bb0150","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/onc.2017.361","article-title":"Circular RNAs in cancer: opportunities and challenges in the field","volume":"37","author":"Kristensen","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.cca.2026.121122_bb0155","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1261\/rna.035667.112","article-title":"Circular RNAs are abundant, conserved, and associated with ALU repeats","volume":"19","author":"Jeck","year":"2013","journal-title":"RNA"},{"key":"10.1016\/j.cca.2026.121122_bb0160","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cell.2014.09.001","article-title":"Complementary sequence-mediated exon circularization","volume":"159","author":"Zhang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.cca.2026.121122_bb0165","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1101\/gad.251926.114","article-title":"Short intronic repeat sequences facilitate circular RNA production","volume":"28","author":"Liang","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/j.cca.2026.121122_bb0170","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","article-title":"The biogenesis, biology and characterization of circular RNAs","volume":"20","author":"Kristensen","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.cca.2026.121122_bb0175","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12943-021-01318-6","article-title":"Comprehensive landscape and future perspectives of circular RNAs in colorectal cancer","volume":"20","author":"Long","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cca.2026.121122_bb0180","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.jmb.2015.02.018","article-title":"Exon skipping is correlated with exon circularization","volume":"427","author":"Kelly","year":"2015","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.cca.2026.121122_bb0185","series-title":"Circular RNAs: Biogenesis and Functions","first-page":"41","article-title":"circular RNA splicing","author":"Eger","year":"2018"},{"key":"10.1016\/j.cca.2026.121122_bb0190","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.molcel.2017.10.034","article-title":"The output of protein-coding genes shifts to circular RNAs when the pre-mRNA processing machinery is limiting","volume":"68","author":"Liang","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cca.2026.121122_bb0195","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.cell.2015.02.014","article-title":"The RNA binding protein quaking regulates formation of circRNAs","volume":"160","author":"Conn","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.cca.2026.121122_bb0200","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s11427-020-1631-9","article-title":"Identification of mecciRNAs and their roles in the mitochondrial entry of proteins","volume":"63","author":"Liu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.cca.2026.121122_bb0205","series-title":"The Long and Short Non-coding RNAs in Cancer Biology","first-page":"1","article-title":"Noncoding RNAs: new players in cancers","author":"Chen","year":"2016"},{"key":"10.1016\/j.cca.2026.121122_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/f782282b-eefa-4c8d-985c-b1484e845855","article-title":"Cell-type specific features of circular RNA expression","volume":"9","author":"Salzman","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.cca.2026.121122_bb0215","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jbiotec.2016.09.011","article-title":"Circular RNAs are miRNA sponges and can be used as a new class of biomarker","volume":"238","author":"Kulcheski","year":"2016","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.cca.2026.121122_bb0220","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.7150\/thno.42174","article-title":"Circular RNA-protein interactions: functions, mechanisms, and identification","volume":"10","author":"Huang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.cca.2026.121122_bb0225","first-page":"1402","article-title":"Foxo3 circular RNA promotes cardiac senescence by modulating multiple factors associated with stress and senescence responses","volume":"38","author":"Du","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cca.2026.121122_bb0230","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.molcel.2017.02.017","article-title":"Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis","volume":"66","author":"Legnini","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cca.2026.121122_bb0235","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41577-019-0173-0","article-title":"The enigma of circular RNA","volume":"19","author":"Flemming","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cca.2026.121122_bb0240","first-page":"658","article-title":"Are circRNAs involved in cancer pathogenesis?","volume":"13","author":"Croce","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cca.2026.121122_bb0245","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.omtn.2020.12.019","article-title":"circFOXM1 contributes to sorafenib resistance of hepatocellular carcinoma cells by regulating MECP2 via miR-1324","volume":"23","author":"Weng","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.cca.2026.121122_bb0250","first-page":"1602","article-title":"Metabolic reprogramming and its clinical implication for liver cancer","volume":"78","author":"Yang","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2026.121122_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.chphi.2026.101054","article-title":"Precision redox oncology: exploiting antioxidant dependencies and oxidative vulnerabilities in cancer","author":"Sulaiman","year":"2026","journal-title":"Chem. Phys. Impact"},{"key":"10.1016\/j.cca.2026.121122_bb0260","first-page":"1","article-title":"Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications","author":"Park","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.cca.2026.121122_bb0265","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1101\/gad.278549.116","article-title":"Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma","volume":"30","author":"Dayton","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.cca.2026.121122_bb0270","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41392-023-01569-3","article-title":"Amino acid metabolism in health and disease","volume":"8","author":"Ling","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cca.2026.121122_bb0275","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrgastro.2017.32","article-title":"Lipid droplets and liver disease: from basic biology to clinical implications","volume":"14","author":"Gluchowski","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cca.2026.121122_bb0280","series-title":"Liver Pathophysiology","first-page":"391","article-title":"Hepatic Metabolism in Liver Health and Disease","author":"Liu","year":"2017"},{"key":"10.1016\/j.cca.2026.121122_bb0285","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.cca.2026.121122_bb0290","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrc3038","article-title":"Otto Warburg's contributions to current concepts of cancer metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cca.2026.121122_bb0295","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.15252\/embj.201490379","article-title":"Aerobic glycolysis tunes YAP\/TAZ transcriptional activity","volume":"34","author":"Enzo","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.cca.2026.121122_bb0300","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nrc.2016.77","article-title":"Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?","volume":"16","author":"Hay","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cca.2026.121122_bb0305","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tibs.2014.06.005","article-title":"The pentose phosphate pathway and cancer","volume":"39","author":"Patra","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.cca.2026.121122_bb0310","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/brv.12140","article-title":"The return of metabolism: biochemistry and physiology of the pentose phosphate pathway","volume":"90","author":"Stincone","year":"2015","journal-title":"Biol. Rev."},{"key":"10.1016\/j.cca.2026.121122_bb0315","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.cell.2010.03.008","article-title":"SnapShot: reactive oxygen intermediates (ROI)","volume":"140","author":"Nathan","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.cca.2026.121122_bb0320","first-page":"606","article-title":"Liver inflammation and hepatobiliary cancers, trends","volume":"7","author":"Leone","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.cca.2026.121122_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101512","article-title":"NADPH oxidases: current aspects and tools","volume":"34","author":"Schr\u00f6der","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.cca.2026.121122_bb0330","series-title":"NADPH Oxidases: Methods and Protocols","first-page":"17","article-title":"Mammalian NADPH oxidases","author":"Buvelot","year":"2019"},{"key":"10.1016\/j.cca.2026.121122_bb0335","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/biomedicines9060687","article-title":"The role of oxidative stress in NAFLD\u2013NASH\u2013HCC transition\u2014focus on NADPH oxidases","volume":"9","author":"Gabbia","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.cca.2026.121122_bb0340","doi-asserted-by":"crossref","first-page":"11060","DOI":"10.1038\/s41598-017-11280-3","article-title":"Gene expression of NOX family members and their clinical significance in hepatocellular carcinoma","volume":"7","author":"Eun","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2026.121122_bb0345","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1080\/10408398.2013.842887","article-title":"The role of dietary cholesterol in lipoprotein metabolism and related metabolic abnormalities: a mini-review","volume":"56","author":"Kapourchali","year":"2016","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.cca.2026.121122_bb0350","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature04399","article-title":"Role of cholesterol and lipid organization in disease","volume":"438","author":"Maxfield","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.cca.2026.121122_bb0355","first-page":"184","article-title":"Regulation and deregulation of cholesterol homeostasis: the liver as a metabolic \u201cpower station\u201d, world","volume":"4","author":"Trapani","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cca.2026.121122_bb0360","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.762828","article-title":"Cholesterol metabolism: a double-edged sword in hepatocellular carcinoma","volume":"9","author":"Zhou","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cca.2026.121122_bb0365","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/hep.22941","article-title":"Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population","volume":"50","author":"Ioannou","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2026.121122_bb0370","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/hep.22904","article-title":"Nutritional model of steatohepatitis and metabolic syndrome in the Ossabaw miniature swine","volume":"50","author":"Lee","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2026.121122_bb0375","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3390\/cells8050512","article-title":"Characterization of lipid and lipid droplet metabolism in human HCC","volume":"8","author":"Berndt","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.cca.2026.121122_bb0380","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.metabol.2014.04.003","article-title":"De novo lipogenesis in health and disease","volume":"63","author":"Ameer","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2026.121122_bb0385","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","article-title":"Reprogramming of fatty acid metabolism in cancer","volume":"122","author":"Koundouros","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cca.2026.121122_bb0390","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s12032-022-01808-7","article-title":"CD36 accelerates the progression of hepatocellular carcinoma by promoting FAs absorption","volume":"39","author":"Tao","year":"2022","journal-title":"Med. Oncol."},{"key":"10.1016\/j.cca.2026.121122_bb0395","doi-asserted-by":"crossref","DOI":"10.1038\/srep14752","article-title":"Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma","volume":"5","author":"Nath","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2026.121122_bb0400","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ajmg.c.30087","article-title":"Disorders of carnitine transport and the carnitine cycle","volume":"142C","author":"Longo","year":"2006","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"key":"10.1016\/j.cca.2026.121122_bb0405","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.3390\/ijms17091430","article-title":"Lipid droplets: a key cellular organelle associated with cancer cell survival under normoxia and hypoxia","volume":"17","author":"Koizume","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2026.121122_bb0410","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.celrep.2014.08.028","article-title":"HIF-1-mediated suppression of acyl-CoA dehydrogenases and fatty acid oxidation is critical for cancer progression","volume":"8","author":"Huang","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.cca.2026.121122_bb0415","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.devcel.2019.05.003","article-title":"Membrane asymmetry imposes directionality on lipid droplet emergence from the ER","volume":"50","author":"Chorlay","year":"2019","journal-title":"Dev. Cell"},{"key":"10.1016\/j.cca.2026.121122_bb0420","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.livres.2019.09.002","article-title":"Lipid droplet dynamics in alcoholic fatty liver disease","volume":"3","author":"Schulze","year":"2019","journal-title":"Liver Res."},{"key":"10.1016\/j.cca.2026.121122_bb0425","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcmgh.2017.05.004","article-title":"Identification of the consistently altered metabolic targets in human hepatocellular carcinoma","volume":"4","author":"Nwosu","year":"2017","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cca.2026.121122_bb0430","doi-asserted-by":"crossref","first-page":"eaan2507","DOI":"10.1126\/science.aan2507","article-title":"A pathology atlas of the human cancer transcriptome","volume":"357","author":"Uhlen","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.cca.2026.121122_bb0435","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.celrep.2018.03.077","article-title":"Molecular characterization and clinical relevance of metabolic expression subtypes in human cancers","volume":"23","author":"Peng","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.cca.2026.121122_bb0440","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41575-019-0217-8","article-title":"Metabolic rearrangements in primary liver cancers: cause and consequences","volume":"16","author":"Satriano","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cca.2026.121122_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/gastro\/goaa066","article-title":"Metabolic alterations and vulnerabilities in hepatocellular carcinoma","volume":"9","author":"Tenen","year":"2021","journal-title":"Gastroenterol. Rep."},{"key":"10.1016\/j.cca.2026.121122_bb0450","doi-asserted-by":"crossref","first-page":"72","DOI":"10.15430\/JCP.2019.24.2.72","article-title":"Therapeutic effects of amino acids in liver diseases: current studies and future perspectives","volume":"24","author":"Lee","year":"2019","journal-title":"J. Cancer Prev."},{"key":"10.1016\/j.cca.2026.121122_bb0455","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1515\/med-2022-0589","article-title":"Amino acid profiles in the tissue and serum of patients with liver cancer","volume":"17","author":"Liu","year":"2022","journal-title":"Open Med."},{"key":"10.1016\/j.cca.2026.121122_bb0460","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.597608","article-title":"Intracellular transport in cancer metabolic reprogramming","volume":"8","author":"Sneeggen","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cca.2026.121122_bb0465","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1242059","article-title":"Glutamine metabolic reprogramming in hepatocellular carcinoma","volume":"10","author":"Ye","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.cca.2026.121122_bb0470","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nrc.2016.71","article-title":"From Krebs to clinic: glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cca.2026.121122_bb0475","first-page":"790","article-title":"Enhancing the efficacy of glutamine metabolism inhibitors in cancer therapy, trends","volume":"7","author":"Yang","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.cca.2026.121122_bb0480","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1172\/JCI69600","article-title":"Glutamine and cancer: cell biology, physiology, and clinical opportunities","volume":"123","author":"Hensley","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2026.121122_bb0485","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s13277-014-2725-z","article-title":"Genetic variations in the one-carbon metabolism pathway genes and susceptibility to hepatocellular carcinoma risk: a case\u2013control study","volume":"36","author":"Zhang","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.cca.2026.121122_bb0490","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1158\/1055-9965.EPI-13-0497","article-title":"Prediagnostic levels of serum one-carbon metabolites and risk of hepatocellular carcinoma","volume":"22","author":"Butler","year":"2013","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.cca.2026.121122_bb0495","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1017\/S0007114509243054","article-title":"Lymphocytic mitochondrial DNA deletions, biochemical folate status and hepatocellular carcinoma susceptibility in a case\u2013control study","volume":"102","author":"Wu","year":"2009","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.cca.2026.121122_bb0500","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jhep.2013.04.031","article-title":"Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis","volume":"59","author":"Frau","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cca.2026.121122_bb0505","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1530-0277.2010.01404.x","article-title":"The hepatocarcinogenic effect of methionine and choline deficient diets: an adaptation to the Warburg effect?","volume":"35","author":"Mato","year":"2011","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.cca.2026.121122_bb0510","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.2353\/ajpath.2006.050989","article-title":"Epigenetic instability and chromosomal instability in hepatocellular carcinoma","volume":"168","author":"Katoh","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cca.2026.121122_bb0515","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1101\/sqb.2011.76.010975","article-title":"Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenases","volume":"76","author":"Kaelin","year":"2011","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"10.1016\/j.cca.2026.121122_bb0520","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ncb3124","article-title":"Metabolic pathways promoting cancer cell survival and growth","volume":"17","author":"Boroughs","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cca.2026.121122_bb0525","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.cca.2026.121122_bb0530","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1172\/JCI31178","article-title":"Indoleamine 2,3-dioxygenase and tumor-induced tolerance","volume":"117","author":"Munn","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2026.121122_bb0535","doi-asserted-by":"crossref","first-page":"12543","DOI":"10.1007\/s00432-023-05083-5","article-title":"New insights into T-cell exhaustion in liver cancer: from mechanism to therapy","volume":"149","author":"Hao","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.cca.2026.121122_bb0540","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/aps.2015.41","article-title":"Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy","volume":"36","author":"Sun","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.cca.2026.121122_bb0545","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.clim.2008.08.012","article-title":"Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients","volume":"129","author":"Cai","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cca.2026.121122_bb0550","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/cmi.2014.91","article-title":"NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma","volume":"12","author":"Sun","year":"2015","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cca.2026.121122_bb0555","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/hep.26192","article-title":"Monocyte\/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48\/2B4 interactions","volume":"57","author":"Wu","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2026.121122_bb0560","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/hep.23054","article-title":"Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor","volume":"50","author":"Hoechst","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2026.121122_bb0565","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jhep.2005.05.026","article-title":"Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain a in advanced human hepatocellular carcinomas","volume":"43","author":"Jinushi","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cca.2026.121122_bb0570","first-page":"12","article-title":"Determination of oxidative stress levels and some antioxidant activities in acute and chronic renal failure patients","volume":"7","author":"Sulaiman","year":"2021","journal-title":"Int. J. Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2026.121122_bb0575","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1264562","article-title":"High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer","volume":"6","author":"Sun","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.cca.2026.121122_bb0580","doi-asserted-by":"crossref","DOI":"10.1002\/cbf.70196","article-title":"Comprehensive overview of therapeutic strategies in colon cancer: chemotherapy, targeted therapy, and immunotherapy","volume":"44","author":"Sulaiman","year":"2026","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.cca.2026.121122_bb0585","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.cca.2026.121122_bb0590","doi-asserted-by":"crossref","first-page":"7208","DOI":"10.3390\/ijms23137208","article-title":"Macrophage polarization: learning to manage it","volume":"23","author":"Lampiasi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2026.121122_bb0595","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000304","article-title":"Single-cell transcriptome analysis reveals the key genes associated with macrophage polarization in liver cancer","volume":"7","author":"Ding","year":"2023","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.cca.2026.121122_bb0600","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jare.2023.08.011","article-title":"Liver metastases across cancer types sharing tumor environment immunotolerance can impede immune response therapy and immune monitoring","volume":"61","author":"Gao","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.cca.2026.121122_bb0605","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41575-018-0020-y","article-title":"Liver sinusoidal endothelial cells\u2014gatekeepers of hepatic immunity","volume":"15","author":"Shetty","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cca.2026.121122_bb0610","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1055\/s-0037-1617455","article-title":"Liver sinusoidal endothelial cell: an update","volume":"37","author":"DeLeve","year":"2017","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.cca.2026.121122_bb0615","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.4049\/jimmunol.1000332","article-title":"In hepatic fibrosis, liver sinusoidal endothelial cells acquire enhanced immunogenicity","volume":"185","author":"Connolly","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.cca.2026.121122_bb0620","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.immuni.2015.08.023","article-title":"The cellular and molecular basis of translational immunometabolism","volume":"43","author":"Norata","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.cca.2026.121122_bb0625","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/ni.3415","article-title":"Emerging concepts of T cell metabolism as a target of immunotherapy","volume":"17","author":"Chang","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cca.2026.121122_bb0630","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fimmu.2016.00020","article-title":"T cells and cancer: how metabolism shapes immunity","volume":"7","author":"Molon","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2026.121122_bb0635","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1158\/0008-5472.CAN-16-2938","article-title":"Deletion of lactate dehydrogenase-a in myeloid cells triggers antitumor immunity","volume":"77","author":"Seth","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.cca.2026.121122_bb0640","first-page":"1","article-title":"Biochemical insights into oxidative stress in colon cancer patients","author":"Sulaiman","year":"2025","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.cca.2026.121122_bb0645","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1172\/JCI80006","article-title":"Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages","volume":"125","author":"Ugel","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2026.121122_bb0650","doi-asserted-by":"crossref","first-page":"19956","DOI":"10.18632\/oncotarget.4648","article-title":"Treg: tolerance vs immunity","volume":"6","author":"Biswas","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.cca.2026.121122_bb0655","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1084\/jem.20151159","article-title":"T cell metabolism drives immunity","volume":"212","author":"Buck","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cca.2026.121122_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114601","article-title":"Metabolic codependencies in the tumor microenvironment and gastric cancer: difficulties and opportunities","volume":"162","author":"Zhao","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cca.2026.121122_bb0665","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12964-018-0262-x","article-title":"Nrf2 activation drive macrophages polarization and cancer cell epithelial-mesenchymal transition during interaction","volume":"16","author":"Feng","year":"2018","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.cca.2026.121122_bb0670","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ecl.2007.07.003","article-title":"Immunosuppressive agents: effects on glucose and lipid metabolism","volume":"36","author":"Subramanian","year":"2007","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.cca.2026.121122_bb0675","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41419-019-1420-9","article-title":"Tryptophan-kynurenine pathway attenuates \u03b2-catenin-dependent pro-parasitic role of STING-TICAM2-IRF3-IDO1 signalosome in toxoplasma gondii infection","volume":"10","author":"Majumdar","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cca.2026.121122_bb0680","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006728","article-title":"Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2\/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes","volume":"11","author":"Solvay","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.cca.2026.121122_bb0685","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s40168-023-01606-x","article-title":"High-fat diet-disturbed gut microbiota-colonocyte interactions contribute to dysregulating peripheral tryptophan-kynurenine metabolism","volume":"11","author":"Sun","year":"2023","journal-title":"Microbiome"},{"key":"10.1016\/j.cca.2026.121122_bb0690","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/cas.15182","article-title":"Stemness and immune evasion conferred by the TDO2-AHR pathway are associated with liver metastasis of colon cancer","volume":"113","author":"Miyazaki","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cca.2026.121122_bb0695","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41392-023-01605-2","article-title":"STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia","volume":"8","author":"Huang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cca.2026.121122_bb0700","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/hep.30671","article-title":"Circular RNA MAT2B promotes glycolysis and malignancy of hepatocellular carcinoma through the miR-338-3p\/PKM2 axis under hypoxic stress","volume":"70","author":"Li","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2026.121122_bb0705","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13046-023-02624-1","article-title":"CircFOXK2 promotes hepatocellular carcinoma progression and leads to a poor clinical prognosis via regulating the Warburg effect","volume":"42","author":"Zheng","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cca.2026.121122_bb0710","article-title":"A mammalian conserved circular RNA CircLARP1B regulates hepatocellular carcinoma metastasis and lipid metabolism","volume":"11","author":"Li","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.cca.2026.121122_bb0715","article-title":"Circular RNA circGSK3B promotes cell proliferation, migration, and invasion by sponging miR-1265 and regulating CAB39 expression in hepatocellular carcinoma","volume":"10","author":"Li","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cca.2026.121122_bb0720","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41419-017-0204-3","article-title":"circHIPK3 regulates cell proliferation and migration by sponging miR-124 and regulating AQP3 expression in hepatocellular carcinoma","volume":"9","author":"Chen","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cca.2026.121122_bb0725","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/hep.31068","article-title":"Circular RNA sequencing identifies CircASAP1 as a key regulator in hepatocellular carcinoma metastasis","volume":"72","author":"Hu","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2026.121122_bb0730","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.29270","article-title":"Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression","volume":"66","author":"Han","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2026.121122_bb0735","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/1878-0261.12424","article-title":"Circular RNA profiling identifies circADAMTS13 as a miR-484 sponge which suppresses cell proliferation in hepatocellular carcinoma","volume":"13","author":"Qiu","year":"2019","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.cca.2026.121122_bb0740","doi-asserted-by":"crossref","first-page":"17775","DOI":"10.1002\/jcp.28403","article-title":"Downregulation of circDYNC1H1 exhibits inhibitor effect on cell proliferation and migration in hepatocellular carcinoma through miR-140-5p","volume":"234","author":"Wang","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cca.2026.121122_bb0745","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1111\/jcmm.15162","article-title":"RETRACTED: circular RNA circFBXO11 modulates hepatocellular carcinoma progress and oxaliplatin resistance through miR-605\/FOXO3\/ABCB1 axis","volume":"24","author":"Li","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.cca.2026.121122_bb0750","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.2147\/OTT.S158008","article-title":"circSMAD2 inhibits the epithelial\u2013mesenchymal transition by targeting miR-629 in hepatocellular carcinoma","volume":"11","author":"Zhang","year":"2018","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.cca.2026.121122_bb0755","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hep.30795","article-title":"A noncoding regulatory RNAs network driven by Circ-CDYL acts specifically in the early stages hepatocellular carcinoma","volume":"71","author":"Wei","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2026.121122_bb0760","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/carcin\/bgab068","article-title":"CircRNA UBAP2 serves as a sponge of miR-1294 to increase tumorigenesis in hepatocellular carcinoma through regulating c-Myc expression","volume":"42","author":"Yu","year":"2021","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cca.2026.121122_bb0765","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12943-018-0909-7","article-title":"CircSLC3A2 functions as an oncogenic factor in hepatocellular carcinoma by sponging miR-490-3p and regulating PPM1F expression","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cca.2026.121122_bb0770","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13046-019-1041-2","article-title":"CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth","volume":"38","author":"Xu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cca.2026.121122_bb0775","doi-asserted-by":"crossref","first-page":"7739","DOI":"10.2147\/CMAR.S259424","article-title":"Exosomal Circ-ZNF652 promotes cell proliferation, migration, invasion and glycolysis in hepatocellular carcinoma via miR-29a-3p\/GUCD1 axis","volume":"12","author":"Li","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.cca.2026.121122_bb0780","first-page":"674","article-title":"Exosomal circFBLIM1 promotes hepatocellular carcinoma progression and glycolysis by regulating the miR-338\/LRP6 axis","volume":"38","author":"Lai","year":"2023","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.cca.2026.121122_bb0785","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2021.03.136","article-title":"CircRNA circBACH1 (hsa_circ_0061395) serves as a miR-656-3p sponge to facilitate hepatocellular carcinoma progression through increasing SERBP1 expression","volume":"556","author":"Li","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2026.121122_bb0790","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12943-020-01222-5","article-title":"Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cca.2026.121122_bb0795","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/1440-1681.13273","article-title":"Downregulation of circular RNA circPVT1 restricts cell growth of hepatocellular carcinoma through downregulation of sirtuin 7 via microRNA-3666","volume":"47","author":"Li","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.cca.2026.121122_bb0800","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s10528-022-10239-y","article-title":"Silencing CircEIF3I\/miR-526b-5p axis epigenetically targets HGF\/c-met signal to hinder the malignant growth, metastasis and angiogenesis of hepatocellular carcinoma","volume":"61","author":"Liu","year":"2023","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.cca.2026.121122_bb0805","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.3748\/wjg.v25.i16.1964","article-title":"Role and mechanism of circ-PRKCI in hepatocellular carcinoma","volume":"25","author":"Qi","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cca.2026.121122_bb0810","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41419-020-2532-y","article-title":"The circular RNA circMAST1 promotes hepatocellular carcinoma cell proliferation and migration by sponging miR-1299 and regulating CTNND1 expression","volume":"11","author":"Yu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cca.2026.121122_bb0815","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/1878-0261.12045","article-title":"Zkscan1 gene and its related circular RNA (circZKSCAN1) both inhibit hepatocellular carcinoma cell growth, migration, and invasion but through different signaling pathways","volume":"11","author":"Yao","year":"2017","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.cca.2026.121122_bb0820","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12943-020-01213-6","article-title":"Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p\/snail\/DPP4 axis","volume":"19","author":"Huang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cca.2026.121122_bb0825","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12943-020-01281-8","article-title":"N6-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating \u03b2-catenin signaling","volume":"19","author":"Xu","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cca.2026.121122_bb0830","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13059-019-1685-4","article-title":"Translation of the circular RNA circ\u03b2-catenin promotes liver cancer cell growth through activation of the Wnt pathway","volume":"20","author":"Liang","year":"2019","journal-title":"Genome Biol."},{"key":"10.1016\/j.cca.2026.121122_bb0835","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13046-020-1529-9","article-title":"Exosomal circRNA-100338 promotes hepatocellular carcinoma metastasis via enhancing invasiveness and angiogenesis","volume":"39","author":"Huang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cca.2026.121122_bb0840","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.aohep.2020.01.002","article-title":"Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p\/HK2 axis","volume":"19","author":"Ding","year":"2020","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.cca.2026.121122_bb0845","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3390\/ddc2030037","article-title":"Unmasking the Warburg effect: unleashing the power of enzyme inhibitors for cancer therapy","volume":"2","author":"Angulo-Elizari","year":"2023","journal-title":"Drugs Drug Candidates"},{"key":"10.1016\/j.cca.2026.121122_bb0850","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41420-022-01062-w","article-title":"Emerging functions of circular RNA in the regulation of adipocyte metabolism and obesity","volume":"8","author":"Zhang","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.cca.2026.121122_bb0855","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.140134","article-title":"MiRNA-155: a double-edged sword in colorectal cancer progression and drug resistance mechanisms","volume":"299","author":"Hussen","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.cca.2026.121122_bb0860","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3892\/mmr.2021.12103","article-title":"Circ-PRKCI targets miR-1294 and miR-186-5p by downregulating FOXK1 expression to suppress glycolysis in hepatocellular carcinoma","volume":"23","author":"Chen","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cca.2026.121122_bb0865","first-page":"863","article-title":"Circular RNA circ_0091579 promotes hepatocellular carcinoma proliferation, migration, invasion, and glycolysis through miR-490-5p\/CASC3 axis","volume":"36","author":"Liu","year":"2021","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.cca.2026.121122_bb0870","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1007\/s10620-020-06805-2","article-title":"Circular RNA circZFR promotes hepatocellular carcinoma progression by regulating miR-375\/HMGA2 axis","volume":"66","author":"Xu","year":"2021","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.cca.2026.121122_bb0875","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s10529-020-02985-z","article-title":"Overexpression of circ_0001445 decelerates hepatocellular carcinoma progression by regulating miR-942-5p\/ALX4 axis","volume":"42","author":"Xu","year":"2020","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.cca.2026.121122_bb0880","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202509989","article-title":"Lactate metabolic reprogramming mediated by CircRNA-LDHA complex facilitates innate immune evasion of liver cancer","volume":"12","author":"Shen","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.cca.2026.121122_bb0885","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41419-024-06743-1","article-title":"Energy stress-induced circDDX21 promotes glycolysis and facilitates hepatocellular carcinogenesis","volume":"15","author":"Luo","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cca.2026.121122_bb0890","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e17120","article-title":"Circular RNA circBNC2 facilitates glycolysis and stemness of hepatocellular carcinoma through the miR-217\/high mobility group AT-hook 2 (HMGA2) axis","volume":"9","author":"Feng","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.cca.2026.121122_bb0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2021.100551","article-title":"Circ_0078710 promotes the development of liver cancer by upregulating TXNDC5 via miR-431-5p","volume":"27","author":"Lu","year":"2022","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.cca.2026.121122_bb0900","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1515\/biol-2022-0029","article-title":"Circ-CFH promotes the development of HCC by regulating cell proliferation, apoptosis, migration, invasion, and glycolysis through the miR-377-3p\/RNF38 axis","volume":"17","author":"Chen","year":"2022","journal-title":"Open Life Sci."},{"key":"10.1016\/j.cca.2026.121122_bb0905","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ncrna.2025.11.006","article-title":"The regulatory role of circGDI2 in hepatocellular carcinoma proliferation and glycolysis with the involvement of m6A modification","volume":"17","author":"Chen","year":"2026","journal-title":"Noncoding RNA Res."},{"key":"10.1016\/j.cca.2026.121122_bb0910","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12951-024-02582-6","article-title":"Exosome-derived circUPF2 enhances resistance to targeted therapy by redeploying ferroptosis sensitivity in hepatocellular carcinoma","volume":"22","author":"Dong","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.cca.2026.121122_bb0915","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41467-024-55577-0","article-title":"The protein circPETH-147aa regulates metabolic reprogramming in hepatocellular carcinoma cells to remodel immunosuppressive microenvironment","volume":"16","author":"Lan","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cca.2026.121122_bb0920","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: a nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cca.2026.121122_bb0925","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cca.2026.121122_bb0930","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.cca.2026.121122_bb0935","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cmet.2012.06.001","article-title":"Metabolic regulation of epigenetics","volume":"16","author":"Lu","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.cca.2026.121122_bb0940","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cell.2013.03.004","article-title":"Influence of metabolism on epigenetics and disease","volume":"153","author":"Kaelin","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.cca.2026.121122_bb0945","doi-asserted-by":"crossref","first-page":"736","DOI":"10.36472\/msd.v10i10.1037","article-title":"Exploring the impact of trace elements and heavy metals on colon cancer","volume":"10","author":"Sulaiman","year":"2023","journal-title":"Med. Sci. Discov."},{"key":"10.1016\/j.cca.2026.121122_bb0950","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/03602532.2025.2560487","article-title":"Analytical techniques for methyldopa and metabolites: a comprehensive review","volume":"57","author":"Barzani","year":"2025","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.cca.2026.121122_bb0955","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1111\/cas.15365","article-title":"Exosomal circGSE1 promotes immune escape of hepatocellular carcinoma by inducing the expansion of regulatory T cells","volume":"113","author":"Huang","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cca.2026.121122_bb0960","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12943-023-01759-1","article-title":"Exosome-derived circCCAR1 promotes CD8+ T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma","volume":"22","author":"Hu","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cca.2026.121122_bb0965","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jhep.2009.12.005","article-title":"T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B","volume":"52","author":"Ju","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cca.2026.121122_bb0970","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/cas.15238","article-title":"hsa_circ_0003410 promotes hepatocellular carcinoma progression by increasing the ratio of M2\/M1 macrophages through the miR-139-3p\/CCL5 axis","volume":"113","author":"Cao","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cca.2026.121122_bb0975","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.2147\/IJN.S284560","article-title":"Downregulation of hsa_circ_0074854 suppresses the migration and invasion in hepatocellular carcinoma via interacting with HuR and via suppressing exosomes-mediated macrophage M2 polarization","volume":"16","author":"Wang","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.cca.2026.121122_bb0980","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10528-022-10273-w","article-title":"CircSOD2 contributes to tumor progression, immune evasion and anti-PD-1 resistance in hepatocellular carcinoma by targeting miR-497-5p\/ANXA11 axis","volume":"61","author":"Ye","year":"2023","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.cca.2026.121122_bb0985","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.143246","article-title":"Circular RNA CDYL facilitates hepatocellular carcinoma stemness and PD-L1+ exosomes-mediated immunotherapy resistance via stabilizing hornerin protein by blocking synoviolin 1-mediated ubiquitination","volume":"310","author":"Fu","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.cca.2026.121122_bb0990","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40164-023-00378-2","article-title":"Hypoxia-associated circPRDM4 promotes immune escape via HIF-1\u03b1 regulation of PD-L1 in hepatocellular carcinoma","volume":"12","author":"Chen","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.cca.2026.121122_bb0995","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.omto.2022.02.021","article-title":"CircRHBDD1 augments metabolic rewiring and restricts immunotherapy efficacy via m6A modification in hepatocellular carcinoma","volume":"24","author":"Cai","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.cca.2026.121122_bb1000","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13045-021-01207-x","article-title":"Amplification of spatially isolated adenosine pathway by tumor\u2013macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma","volume":"14","author":"Lu","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cca.2026.121122_bb1005","first-page":"388","article-title":"circRNA of AR-suppressed PABPC1 91 bp enhances the cytotoxicity of natural killer cells against hepatocellular carcinoma via upregulating UL16 binding protein 1","volume":"17","author":"Ma","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.cca.2026.121122_bb1010","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s11658-022-00406-9","article-title":"Exosomal miR-628-5p from M1 polarized macrophages hinders m6A modification of circFUT8 to suppress hepatocellular carcinoma progression","volume":"27","author":"Wang","year":"2022","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.cca.2026.121122_bb1015","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1002\/tox.24188","article-title":"Circ_0027791 contributes to the growth and immune evasion of hepatocellular carcinoma via the miR-496\/programmed cell death ligand 1 axis in an m6A-dependent manner","volume":"39","author":"Yu","year":"2024","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.cca.2026.121122_bb1020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s40164-022-00342-6","article-title":"circRanGAP1\/miR-27b-3p\/NRAS axis may promote the progression of hepatocellular carcinoma","volume":"11","author":"Lin","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.cca.2026.121122_bb1025","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41419-020-2616-8","article-title":"Circular RNA circZNF566 promotes hepatocellular carcinoma progression by sponging miR-4738-3p and regulating TDO2 expression","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cca.2026.121122_bb1030","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41419-020-02807-0","article-title":"CircularRNA-9119 protects hepatocellular carcinoma cells from apoptosis by intercepting miR-26a\/JAK1\/STAT3 signaling","volume":"11","author":"Yang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cca.2026.121122_bb1035","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1080\/21655979.2022.2032972","article-title":"Cancer-associated fibroblast exosomes promote chemoresistance to cisplatin in hepatocellular carcinoma through circZFR targeting signal transducers and activators of transcription (STAT3)\/nuclear factor-kappa B (NF-\u03baB) pathway","volume":"13","author":"Zhou","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.cca.2026.121122_bb1040","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2022.101877","article-title":"Circular RNA ITCH increases sorafenib-sensitivity in hepatocellular carcinoma via sequestering miR-20b-5p and modulating the downstream PTEN-PI3K\/Akt pathway","volume":"67","author":"Li","year":"2023","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.cca.2026.121122_bb1045","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12943-024-02224-3","article-title":"CircTTC13 promotes sorafenib resistance in hepatocellular carcinoma through the inhibition of ferroptosis by targeting the miR-513a-5p\/SLC7A11 axis","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cca.2026.121122_bb1050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12943-019-1031-1","article-title":"Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression","volume":"18","author":"Zhang","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cca.2026.121122_bb1055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216484","article-title":"Emerging role of circular RNAs in hepatocellular carcinoma immunotherapy","volume":"24","author":"Abaza","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2026.121122_bb1060","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10555-023-10084-4","article-title":"Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers","volume":"42","author":"Wang","year":"2023","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.cca.2026.121122_bb1065","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13483","article-title":"Efficacy and safety of PD1\/PDL1 blockade with platinum-based chemotherapy for extensive small cell lung cancer: a pooled analysis of randomized trials","volume":"51","author":"Messina","year":"2021","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.cca.2026.121122_bb1070","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1002\/eji.202048994","article-title":"Mechanism of action of PD-1 receptor\/ligand targeted cancer immunotherapy","volume":"51","author":"Borst","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cca.2026.121122_bb1075","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3389\/fimmu.2020.01037","article-title":"Anti-PD-1\/PD-L1 blockade immunotherapy employed in treating hepatitis B virus infection-related advanced hepatocellular carcinoma: a literature review","volume":"11","author":"Li","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2026.121122_bb1080","article-title":"Immunomodulatory effects of regorafenib: enhancing the efficacy of anti-PD-1\/PD-L1 therapy","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2026.121122_bb1085","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1136\/gutjnl-2020-322196","article-title":"High-affinity neoantigens correlate with better prognosis and trigger potent antihepatocellular carcinoma (HCC) activity by activating CD39+ CD8+ T cells","volume":"70","author":"Liu","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.cca.2026.121122_bb1090","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216872","article-title":"Tumor-associated macrophage-induced circMRCK\u03b1 encodes a peptide to promote glycolysis and progression in hepatocellular carcinoma","volume":"591","author":"Yu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cca.2026.121122_bb1095","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.cca.2026.121122_bb1100","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107628","article-title":"Single-cell RNA sequencing reveals a dynamic stromal niche that supports tumor growth","volume":"31","author":"Davidson","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.cca.2026.121122_bb1105","first-page":"4190","article-title":"Circ_0056618 promoted cell proliferation, migration and angiogenesis through sponging with miR-206 and upregulating CXCR4 and VEGF-A in colorectal cancer","volume":"24","author":"Zheng","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.cca.2026.121122_bb1110","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13046-020-01691-y","article-title":"The U2AF2\/circRNA ARF1\/miR-342-3p\/ISL2 feedback loop regulates angiogenesis in glioma stem cells","volume":"39","author":"Jiang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cca.2026.121122_bb1115","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12943-020-01208-3","article-title":"Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p\/HUR\/VEGF axis and suppressing HSP90 degradation","volume":"19","author":"Xie","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cca.2026.121122_bb1120","first-page":"1","article-title":"The analytical evolution of glibenclamide (glyburide) antidiabetic agents: analytical tools, challenges, and future trends","author":"Barzani","year":"2025","journal-title":"Crit. Rev. Anal. Chem."},{"key":"10.1016\/j.cca.2026.121122_bb1125","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.610661","article-title":"Resistance mechanisms of anti-angiogenic therapy and exosomes-mediated revascularization in cancer","volume":"8","author":"Zeng","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cca.2026.121122_bb1130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10456-019-09698-6","article-title":"Vessel co-option and resistance to anti-angiogenic therapy","volume":"23","author":"Kuczynski","year":"2020","journal-title":"Angiogenesis"},{"key":"10.1016\/j.cca.2026.121122_bb1135","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1007\/s11033-020-05515-2","article-title":"Vascular mimicry: changing the therapeutic paradigms in cancer","volume":"47","author":"Fathi Maroufi","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.cca.2026.121122_bb1140","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10555-021-10000-8","article-title":"The emerging roles of circular RNAs in vessel co-option and vasculogenic mimicry: clinical insights for anti-angiogenic therapy in cancers","volume":"41","author":"Shao","year":"2022","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.cca.2026.121122_bb1145","first-page":"469","article-title":"Biogenesis, research methods, and functions of circular RNAs","volume":"41","author":"Liu","year":"2019","journal-title":"Hereditas (Beijing)"},{"key":"10.1016\/j.cca.2026.121122_bb1150","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/s41388-017-0019-9","article-title":"A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis","volume":"37","author":"Zhang","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.cca.2026.121122_bb1155","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/jnci\/djx166","article-title":"Novel role of FBXW7 circular RNA in repressing glioma tumorigenesis","volume":"110","author":"Yang","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.cca.2026.121122_bb1160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1227150","article-title":"An emerging research: the role of hepatocellular carcinoma-derived exosomal circRNAs in the immune microenvironment","volume":"14","author":"Xu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2026.121122_bb1165","article-title":"The mechanism and clinical significance of circular RNAs in hepatocellular carcinoma","volume":"11","author":"Huang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cca.2026.121122_bb1170","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41419-023-05647-w","article-title":"Regulation of the tumor immune microenvironment by cancer-derived circular RNAs","volume":"14","author":"Guan","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cca.2026.121122_bb1175","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/hepr.13870","article-title":"circTMEM181 upregulates ARHGAP29 to inhibit hepatocellular carcinoma migration and invasion by sponging miR-519a-5p","volume":"53","author":"Chen","year":"2023","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.cca.2026.121122_bb1180","doi-asserted-by":"crossref","first-page":"12003","DOI":"10.3748\/wjg.v21.i42.12003","article-title":"Diagnostic and therapeutic management of hepatocellular carcinoma","volume":"21","author":"Bellissimo","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cca.2026.121122_bb1185","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3346\/jkms.1998.13.2.103","article-title":"Hepatocarcinogenesis in liver cirrhosis: imaging diagnosis","volume":"13","author":"Choi","year":"1998","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.cca.2026.121122_bb1190","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.canep.2014.10.005","article-title":"Low use of surveillance and early diagnosis of hepatocellular carcinoma in Norway\u2014a population-based cohort study","volume":"38","author":"Eskesen","year":"2014","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.cca.2026.121122_bb1195","first-page":"671","article-title":"Long term (5 years) outcome of radiofrequency ablation for hepatocellular carcinoma in 256 cases","volume":"37","author":"Chen","year":"2005","journal-title":"J. Peking Univ. Health Sci."},{"key":"10.1016\/j.cca.2026.121122_bb1200","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2026.121122_bb1205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27020990","article-title":"CircRNAs in immuno-metabolic reprogramming of chordoma cancer: molecular crosstalk and therapeutic potential","volume":"27","author":"Taghavi Pourianazar","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2026.121122_bb1210","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3892\/ijo.2025.5839","article-title":"Exosomal circRNAs in hepatocellular carcinoma: implications for the development and therapeutic resistance of hepatocellular carcinoma","volume":"68","author":"Liu","year":"2025","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cca.2026.121122_bb1215","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1002\/jcb.28045","article-title":"circRNAs (hsa_circ_00156, hsa_circ_000224, and hsa_circ_000520) are novel potential biomarkers in hepatocellular carcinoma","volume":"120","author":"Matboli","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.cca.2026.121122_bb1220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141214","article-title":"Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood","volume":"10","author":"Memczak","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2026.121122_bb1225","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cca.2017.01.025","article-title":"Using circular RNA hsa_circ_0000190 as a new biomarker in the diagnosis of gastric cancer","volume":"466","author":"Chen","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.121122_bb1230","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12935-020-01302-y","article-title":"Serum-derived three-circRNA signature as a diagnostic biomarker for hepatocellular carcinoma","volume":"20","author":"Sun","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.cca.2026.121122_bb1235","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13045-023-01452-2","article-title":"Exosomal circRNA: emerging insights into cancer progression and clinical application potential","volume":"16","author":"Zhang","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cca.2026.121122_bb1240","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1167717","article-title":"Emerging diversity in extracellular vesicles and their roles in cancer","volume":"13","author":"Sohal","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cca.2026.121122_bb1245","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.568366","article-title":"Emerging roles of exosomal circular RNAs in cancer","volume":"8","author":"Seimiya","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cca.2026.121122_bb1250","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107848","article-title":"Metabolic modulation of immunity: a new concept in cancer immunotherapy","volume":"32","author":"Guerra","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.cca.2026.121122_bb1255","first-page":"335","article-title":"Lactate-mediated acidification of tumor microenvironment induces apoptosis of liver-resident NK cells in colorectal liver metastasis, Cancer","volume":"7","author":"Harmon","year":"2019","journal-title":"Immunol. Res."},{"key":"10.1016\/j.cca.2026.121122_bb1260","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3748\/wjg.v8.i2.193","article-title":"The prognostic significance of clinical and pathological features in hepatocellular carcinoma","volume":"8","author":"Qin","year":"2002","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cca.2026.121122_bb1265","doi-asserted-by":"crossref","first-page":"524","DOI":"10.5858\/1999-123-0524-MAOPFO","article-title":"Morphology and other prognostic factors of hepatocellular carcinoma","volume":"123","author":"Chedid","year":"1999","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.cca.2026.121122_bb1270","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00004836-200012000-00007","article-title":"Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels","volume":"31","author":"Tangkijvanich","year":"2000","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.cca.2026.121122_bb1275","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.598464","article-title":"The roles of circRNAs in liver cancer immunity","volume":"10","author":"Tang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cca.2026.121122_bb1280","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/cmi.2016.3","article-title":"Liver immunology and its role in inflammation and homeostasis","volume":"13","author":"Robinson","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cca.2026.121122_bb1285","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ni.2691","article-title":"Immune surveillance by the liver","volume":"14","author":"Jenne","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cca.2026.121122_bb1290","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/cells9010137","article-title":"RNA-based therapeutics: from antisense oligonucleotides to miRNAs","volume":"9","author":"Bajan","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.cca.2026.121122_bb1295","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev-biophys-083012-130404","article-title":"Molecular mechanisms of RNA interference","volume":"42","author":"Wilson","year":"2013","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.cca.2026.121122_bb1300","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/nat.2016.0656","article-title":"Molecular mechanisms of antisense oligonucleotides","volume":"27","author":"Crooke","year":"2017","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.cca.2026.121122_bb1305","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cca.2026.121122_bb1310","doi-asserted-by":"crossref","first-page":"17181","DOI":"10.1074\/jbc.M311683200","article-title":"Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs","volume":"279","author":"Wu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2026.121122_bb1315","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11011-025-01778-5","article-title":"Brain lipid metabolism and transport: implications for neurodegeneration and therapeutic strategies: a comprehensive review","volume":"41","author":"Qadir","year":"2026","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.cca.2026.121122_bb1320","article-title":"Evolving analytical methods for the quantification of methocarbamol: a critical review","volume":"40","author":"Barzani","year":"2026","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.cca.2026.121122_bb1325","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jconrel.2022.10.050","article-title":"Nano drug delivery systems for antisense oligonucleotides (ASO) therapeutics","volume":"352","author":"Ramasamy","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.cca.2026.121122_bb1330","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41573-021-00162-z","article-title":"Antisense technology: an overview and prospectus","volume":"20","author":"Crooke","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cca.2026.121122_bb1335","first-page":"1245","article-title":"The complexity of the translation ability of circRNAs","volume":"2016","author":"Granados-Riveron","year":"1859","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"10.1016\/j.cca.2026.121122_bb1340","first-page":"1025","article-title":"Non-coding transcript variants of protein-coding genes\u2013what are they good for?","volume":"15","author":"Dhamija","year":"2018","journal-title":"RNA Biol."},{"key":"10.1016\/j.cca.2026.121122_bb1345","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3389\/fphar.2018.01295","article-title":"Peptides\/proteins encoded by non-coding RNA: a novel resource bank for drug targets and biomarkers","volume":"9","author":"Zhu","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cca.2026.121122_bb1350","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12943-018-0934-6","article-title":"The novel roles of circRNAs in human cancer","volume":"18","author":"Shang","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cca.2026.121122_bb1355","first-page":"1204","article-title":"Interleukin-6 as a biomarker for breast cancer prognosis and therapeutic response","volume":"9","author":"Sulaiman","year":"2024","journal-title":"Qalaai Zanist Sci. J."},{"key":"10.1016\/j.cca.2026.121122_bb1360","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jhep.2023.03.003","article-title":"Combination immunotherapy for hepatocellular carcinoma","volume":"79","author":"Rimassa","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cca.2026.121122_bb1365","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2026.121122_bb1370","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jhep.2020.11.026","article-title":"Systemic treatment of HCC in special populations","volume":"74","author":"Rimassa","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cca.2026.121122_bb1375","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jhep.2021.04.047","article-title":"CheckMate 040 cohort 5: a phase I\/II study of nivolumab in patients with advanced hepatocellular carcinoma and child-Pugh B cirrhosis","volume":"75","author":"Kudo","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cca.2026.121122_bb1380","doi-asserted-by":"crossref","first-page":"12060","DOI":"10.7150\/thno.48918","article-title":"Circulating tumor cells in hepatocellular carcinoma: single-cell based analysis, preclinical models, and clinical applications","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.cca.2026.121122_bb1385","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1722576","article-title":"Circular RNA in hepatocellular carcinoma: emerging therapeutic strategies","volume":"16","author":"Jazbec","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2026.121122_bb1390","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.3390\/biomedicines12071624","article-title":"Preclinical models of hepatocellular carcinoma: current utility, limitations, and challenges","volume":"12","author":"Cigliano","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.cca.2026.121122_bb1395","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/15476286.2017.1279788","article-title":"Identification of HuR target circular RNAs uncovers suppression of PABPN1 translation by CircPABPN1","volume":"14","author":"Abdelmohsen","year":"2017","journal-title":"RNA Biol."},{"key":"10.1016\/j.cca.2026.121122_bb1400","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molcel.2017.02.021","article-title":"Translation of circRNAs","volume":"66","author":"Pamudurti","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cca.2026.121122_bb1405","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/cr.2015.82","article-title":"Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis","volume":"25","author":"Li","year":"2015","journal-title":"Cell Res."},{"key":"10.1016\/j.cca.2026.121122_bb1410","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41590-018-0044-z","article-title":"The immunology of hepatocellular carcinoma","volume":"19","author":"Ringelhan","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cca.2026.121122_bb1415","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.cca.2026.121122_bb1420","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.cell.2017.04.004","article-title":"Metabolic instruction of immunity","volume":"169","author":"Buck","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cca.2026.121122_bb1425","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cmet.2018.03.004","article-title":"RNA-targeted therapeutics","volume":"27","author":"Crooke","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.cca.2026.121122_bb1430","doi-asserted-by":"crossref","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cca.2026.121122_bb1435","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cca.2026.121122_bb1440","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC","volume":"592","author":"Pfister","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.cca.2026.121122_bb1445","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nmeth.1315","article-title":"mRNA-Seq whole-transcriptome analysis of a single cell","volume":"6","author":"Tang","year":"2009","journal-title":"Nat. Methods"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126003049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126003049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:24:24Z","timestamp":1786422264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126003049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":289,"alternative-id":["S0009898126003049"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121122","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CircRNAs as central regulators of Immunometabolic crosstalk in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121122"}}